ACADIA PHARMACEUTICALS INC (ACAD) Gross margin 2016–2023
ACADIA PHARMACEUTICALS INC (ACAD) gross margin by fiscal year — reported gross profit divided by reported revenue.
94.3%FY2023 · since FY2016: 82.2% → 94.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 94.3% | -3.8 pp |
| FY2022 | 98.0% | +0.3 pp |
| FY2021 | 97.8% | +0.1 pp |
| FY2020 | 97.7% | +1.0 pp |
| FY2019 | 96.7% | +2.2 pp |
| FY2018 | 94.5% | +1.7 pp |
| FY2017 | 92.7% | +10.5 pp |
| FY2016 | 82.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice